Advances in patient screenings and breakthrough therapies allow Cystic fibrosis (CF) patients now to live into their mid-to-late 30s or 40s, sometimes even longer. However, even the ~90% of patients ...

Despite advances in patient screenings and breakthrough therapies that allow CF patients now to live into their mid- to late 30s or 40s, sometimes even longer, all patients are plagued by bacteria ...

A team led by researchers at Newcastle University, UK has successfully created a model of the cells found in the lungs that can be used to replicate how COVID-19 infects the airways. This information, ...

One of the challenges facing scientists searching for new ways to combat COVID-19 is that pitting drug candidates against the virus in cell cultures doesn’t accurately predict how effective they’ll ...

What happens in our respiratory tract once we’re exposed to COVID-19? A three-dimensional airway model, made from patient-derived stem cells, could provide answers about the initial stages of ...

Biological assailants like fungi, bacteria, and viruses continuously test natural defenses that have evolved over millennia. Newer and stranger particles that originate from burning fuels, harmful ...

Respiratory diseases are a challenging problem to treat. Inhalable medicines are a promising solution that depend on the ability to deliver tiny particles known as aerosols to the correct location in ...